Application of standard and novel prognostic systems in patients with myelodys- plastic syndrome undergoing allogeneic hematopoietic stem cell transplantation

Q4 Medicine

Cellular Therapy and Transplantation Pub Date : 2019-03-30 DOI:10.18620/CTT-1866-8836-2019-8-1-36-45

E. Morozova, M. Barabanshikova, Nikolai Y. Tcvetkov, Ksenia V. Melsitova, Julia V. Rudnitskaya, E. I. Darskaya, S. Bondarenko, I. Moiseev, B. Afanasyev

引用次数: 1

Abstract

Elena V. Morozova, Maria V. Barabanshikova, Nikolai Yu. Tcvetkov, Ksenia V. Melsitova, Julia V. Rudnitskaya, Elena I. Darskaya, Sergey N. Bondarenko, Ivan S. Moiseev, Boris V. Afanasyev R. Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, The First Pavlov St. Petersburg State Medical University, St. Petersburg, Russian Federation Application of standard and novel prognostic systems in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation Cellular Therapy and Transplantation (CTT). Vol. 8, No. 1, 2019 doi: 10.18620/ctt-1866-8836-2019-8-1-36-45 Submitted: 06 March 2019, accepted: 15 March 2019

查看原文本刊更多论文

标准和新型预后系统在异基因造血干细胞移植骨髓增生综合征患者中的应用

Elena V. Morozova, Maria V. Barabanshikova, Nikolai Yu。Tcvetkov, Ksenia V. Melsitova, Julia V. Rudnitskaya, Elena I. Darskaya, Sergey N. Bondarenko, Ivan S. Moiseev, Boris V. Afanasyev R. gorbachev儿童肿瘤、血液学和移植纪念研究所，第一巴甫洛夫圣彼得堡国立医科大学，圣彼得堡标准和新型预后系统在接受异基因造血干细胞移植的骨髓增生异常综合征患者中的应用。《科学》第8卷第1期，2019年doi: 10.18620/ctt-1866-8836-2019-8-1-36-45提交时间:2019年3月6日，接受时间:2019年3月15日

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cellular Therapy and Transplantation Medicine-Transplantation

CiteScore

0.60

自引率

0.00%

发文量